Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion type Assertion NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_head.
- NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion description "[We suggest that some of the other features present in more than one patient with deletion, including hypotonia, sleep apnea, chronic constipation, gastroesophageal and vesicoureteral refluxes, epilepsy, ataxia, dysphagia, nystagmus, and ptosis may result from deletion of the CHAT gene, encoding choline acetyltransferase, and the SLC18A3 gene, mapping in the first intron of CHAT and encoding vesicular acetylcholine transporter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_provenance.
- NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion evidence source_evidence_literature NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_provenance.
- NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion SIO_000772 21948486 NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_provenance.
- NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion wasDerivedFrom befree-2016 NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_provenance.
- NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_assertion wasGeneratedBy ECO_0000203 NP926505.RAQ7KpT2TPS83bnuxC22tt7h43JQv0F4m4vxdcQVaxEcE130_provenance.